Knight, Therapeutics

Knight Therapeutics firma un acuerdo de licencia exclusiva con Amneal Pharmaceuticals para IPX203

Published on 08/07/2025 at 18:02 | prnewswire.co.uk

Knight Therapeutics Inc. Quebec

View original content to download multimedia:https://www.prnewswire.com/mx/comunicados-de-prensa/knight-therapeutics-firma-un-acuerdo-de-licencia-exclusiva-con-amneal-pharmaceuticals-para-ipx203-302044104.html

FUENTE Knight Therapeutics Inc.

en | boerse | 68003909 |